Loss of heterozygosity (LOH) with very high allelic frequency was observed in NOTCH3, TGFB1, EZH2 and KMT2C in the patient tumor, the subcutaneous PDX and the PDOX. This evidence concerns the gene EZH2 and neoplasm.